Kura Oncology (KURA) Cash & Equivalents (2010 - 2026)
Kura Oncology's Cash & Equivalents was $70.24 million in Q2 2026, down 14.3% from $81.95 million a year earlier but up 79.7% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Kura Oncology came in at $149.1 million, down 33.6% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -14.5% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $224.46 million in FY2024 (+501.5%), $37.32 million in FY2023 (-28.0%), $51.8 million in FY2022 (-42.9%) and $90.67 million in FY2021 (-72.1%).
- Quarterly Cash & Equivalents has moved between $27.06 million (Q1 2023) and $224.46 million (Q4 2024) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for three straight quarters, with growth averaging 87.4% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2024 (growth of 501.5%); the worst was Q4 2021 (a decline of 72.1%).
- Per Business Quant data, KURA's Cash & Equivalents in the three quarters before Q2 2026 was $39.08 million (Q1 2026), $149.1 million (Q4 2025) and $95.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | 70.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.24 Mn |
| Mar 31, 2026 | 39.08 Mn |
| Dec 31, 2025 | 149.10 Mn |
| Sep 30, 2025 | 95.29 Mn |
| Jun 30, 2025 | 81.95 Mn |
| Mar 31, 2025 | 51.27 Mn |
| Dec 31, 2024 | 224.46 Mn |
| Sep 30, 2024 | 49.48 Mn |
| Jun 30, 2024 | 45.18 Mn |
| Mar 31, 2024 | 41.51 Mn |
| Dec 31, 2023 | 37.32 Mn |
| Sep 30, 2023 | 28.74 Mn |
| Jun 30, 2023 | 49.12 Mn |
| Mar 31, 2023 | 27.06 Mn |
| Dec 31, 2022 | 51.80 Mn |
| Sep 30, 2022 | 90.94 Mn |
| Jun 30, 2022 | 39.26 Mn |
| Mar 31, 2022 | 33.83 Mn |
| Dec 31, 2021 | 90.67 Mn |
| Sep 30, 2021 | 39.18 Mn |
API Access
Kura Oncology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();